The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

Build return packaging for two journeys: scannable codes, secure seals and right-sized mono-material formats with simple ...

Novartis (NVS) announced positive results from KALUMA, a Phase III study for new malaria treatment KLU156. The novel non-artemisinin antimalarial, ...

ZURICH, November 13, 2025 - Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, has extended ...

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...

RNA plays a vital role in how our genes are expressed and how diseases develop. Yet, because RNA molecules constantly change ...

Scientists from Academia Sinica and National Taiwan University, together with international collaborators, have developed a ...

The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the agency's top officials said on ...

PACK EXPO Las Vegas 2025, welcomed more than 30,000 attendees and 20,000 exhibitor personnel for a total of 50,000 packaging ...

Shift verification effort from a single, time-consuming flat run to a more efficient, distributed, and scalable process.

Alithea Genomics has gained recognition for transforming RNA sequencing with its scalable and cost-effective solutions.

A report of an explosion near Delhis Radisson Hotel (Mahipalpur) was confirmed unsubstantiated. Police and Fire Services ...